In summary, we demonstrate here that endothelial-derived CTRP9 is required to counteract insulin resistance and myocardial inflammation and to promote mitochondrial metabolism in order to protect from diabetic cardiomyopathy during HFD conditions. This evidence concerns the gene C1QTNF9 and diabetic cardiomyopathy.